ABSTRACT
Recently proposed biomarker-only diagnostic frameworks propose that amyloid-beta is necessary for placement on the Alzheimer's disease continuum, whereas tau in the absence of amyloid-beta is considered to be a non-Alzheimer's disease pathologic change. Similarly, the pathologic designation of tau in the absence of amyloid-beta is characterized as primary age-related tauopathy and separable from Alzheimer's disease. Our study sought to identify an early-to-moderate tau stage with minimal amyloid-beta using PET imaging and characterize these individuals in terms of clinical, cognitive and biological features. Seven hundred and three participants from the Alzheimer's Disease Neuroimaging Initiative were classified into one of the four groups (A-/T-, A-/T+, A+/T- and A+/T+) based on PET positivity or negativity for cortical amyloid-beta (A-/A+) and early-to-moderate stage (i.e. meta-temporal) tau (T-/T+). These groups were then compared on demographic and clinical features, vascular risk, multi-domain neuropsychological performance, multi-domain subjective cognitive complaints, apolipoprotein E epsilon-4 carrier status and cortical thickness across Alzheimer's disease-vulnerable regions. The proportion of participants classified in each group was as follows: 47.23% A-/T-, 13.51% A-/T+, 12.23% A+/T- and 27.03% A+/T+. Results indicated that the A-/T+ and A+/T+ groups did not statistically differ on age, sex, depression levels, vascular risk and cortical thickness across temporal and parietal regions. Additionally, both A-/T+ and A+/T+ groups showed significant associations between memory performance and cortical thickness of temporal regions. Despite the different pathologic terminology used for A-/T+ and A+/T+, these groups did not statistically differ on a number of clinical, cognitive and biomarker features. Although it remains unclear whether A-/T+ reflects a pathologic construct separable from Alzheimer's disease, our results provide evidence that this group typically characterized as 'non-Alzheimer's pathologic change' or 'primary age-related tauopathy' should be given increased attention, given some similarities in cognitive and biomarker characteristics to groups traditionally considered to be on the Alzheimer's continuum.
ABSTRACT
This study investigated the effects of providing lucerne hay on the behaviour and the performance of sows housed in farrowing crates during farrowing and lactation. Seventy-two mixed parity sows received either 1 kg lucerne hay daily from entry into the farrowing crate (-2 d from expected farrowing date) until weaning at 17 d (lucerne group, n = 36), or received no additional enrichment (control group, n = 36). In the 18 h prior to farrowing, the sows in the lucerne treatment spent more time performing nest-building behaviour (14.8% lucerne vs 11.1% control, p = 0.0009) and less time sham-chewing (1.0% lucerne vs 1.9% control, p = 0.01) than control sows, and gave birth to fewer stillborn piglets/litter (0.1 lucerne vs 0.4 control, p = 0.027). After farrowing (Day 3), the control sows spent less time lying than the lucerne sows (26% control vs 43% lucerne, p < 0.05). The control sows also spent less time interacting with their piglets during early lactation compared to late lactation (25.5% Day 5 vs 47.3% Day 12, p < 0.05), suggesting reduced maternal behaviour in this group. The lucerne sows continued to interact with the lucerne throughout lactation, indicating that they still found the enrichment rewarding after the nesting period had ceased. Based on these results, lucerne enrichment was considered to improve sow welfare during farrowing and lactation and reduce the number of stillborn piglets.
ABSTRACT
Studies on farm animals have shown relationships between stockperson attitudes and behaviour and farm animal fear, stress and productivity. This study investigated how the avoidance behaviour of Australian commercial caged laying hens may be related to stockperson behaviour, albumen corticosterone, and the number of weeks producing within 5% of peak egg production. Nineteen laying houses were assessed over 3 days. Fear of humans in hens, based on their avoidance response to an unfamiliar human, was assessed using two behavioural tests. Albumen corticosterone concentrations were measured from egg samples collected immediately prior to behavioural testing. Stockperson attitudes were assessed using a questionnaire and stockperson behaviour was observed over 2 days. Productivity records for each laying house were also obtained. The duration of peak production was negatively related to both noise made by the stockperson and hen avoidance. No relationship between stockperson behaviour or attitudes and hen avoidance was found, but stockpeople with negative attitudes made more noise. In conclusion, this study could not confirm a relationship between stockperson behaviour and hen avoidance behaviour for Australian caged laying hens. However, this study did confirm a relationship between hen avoidance behaviour, albumen corticosterone concentration, and the duration of peak egg production.
ABSTRACT
OBJECTIVE: Depression is increasingly recognized as a risk factor for type 2 diabetes, and is also commonly comorbid with anxiety. However, few studies have examined whether anxiety is predictive of diabetes risk. The objectives of this study are to examine the prospective relationship between anxiety disorders (generalized anxiety disorder, panic disorder, social phobia, and agoraphobia) and risk of type 2 diabetes over an 11-year period, and to investigate the association between anxiety and risk of diabetes-related complications among those with prevalent type 2 diabetes. METHODS: Data come from the 1993/6 and 2004/5 waves of the Baltimore Epidemiologic Catchment Area Study (N=1920), a population-based prospective cohort. Anxiety disorders were assessed using the Diagnostic Interview Schedule. The prospective association between anxiety and incident type 2 diabetes was evaluated using a series of nested multivariable logistic regression models. RESULTS: At baseline, 315 participants (21.8%) had an anxiety disorder. The relationship between anxiety and risk of developing type 2 diabetes was not statistically significant after controlling for demographic characteristics (Odds Ratio (OR): 1.28, 95% Confidence Interval (CI): 0.75, 2.18). There was no relationship between anxiety and diabetes risk after controlling for health behaviors and depression status (OR: 1.00, 95% CI: 0.53, 1.89). There was no significant relationship between anxiety and development of diabetes-related complications among those with prevalent type 2 diabetes (OR: 2.02, 95% CI: 0.61, 6.74). CONCLUSION: Anxiety disorders are not associated with increased risk of type 2 diabetes or risk of diabetes complications among those who have diabetes.
